Tag Archives: AllianceRx

Specialty Pharmacy News Roundup: May 2023

The latest in specialty pharmacy news and research. Stay up to date on companies and industry trends at the forefront of the specialty pharmacy industry

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

Nobelpharma America Selects AllianceRx Walgreens and Total Care Rx to Distribute Hyftor

AllianceRx Walgreens Prime Rebranding as AllianceRx Walgreens Pharmacy

AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand

AllianceRx Walgreens Prime Dispensing Arcalyst and Gavreto

AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease

AllianceRx Walgreens Prime Expanding Digital Clinical Capabilities with Highmark

AllianceRx Walgreens Prime’s digital clinical assessments are available for patients with chronic inflammatory disease, multiple sclerosis, cystic fibrosis, idiopathic pulmonary fibrosis, organ transplants, lipid and blood disorders

Turning Point Rx ‘s Network of Specialty Pharmacies Continues to Grow

The largest specialty pharmacies are owned by organizations that are increasingly integrating their product and service offerings such as CVS Health, Cigna’s Express Scripts, UnitedHealth Group’s OptumRx, and Walgreens Boots Alliance/Prime Therapeutics

AllianceRx Walgreens Prime Aggressively Increasing Digital Capabilities

AllianceRx is continuing to taking steps to help patients with chronic or complex conditions better manage their care online

Biologics by McKesson and AllianceRx Expand Specialty Pharmacy Oncology Offerings

INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies